Orthostatic side effects of clomipramine and moclobemide during treatment for depression.

about

From depression to neurodegeneration and heart failure: re-examining the potential of MAO inhibitors.Sleep Disorders and Their Management in Children With Ehlers-Danlos Syndrome Referred to Sleep Clinics

P2860

Q38040128-BBE47818-D68B-4106-9659-6360C3E8BC2A Q57652403-98EB3EFE-0040-47CA-9D21-77F8B6EB5E28

P2860

Orthostatic side effects of clomipramine and moclobemide during treatment for depression.

Item

http://www.wikidata.org/entity/Q46728681

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Orthostatic side effects of clomipramine and moclobemide during treatment for depression.

@en

Orthostatic side effects of clomipramine and moclobemide during treatment for depression.

@nl

type

Item

label

Orthostatic side effects of clomipramine and moclobemide during treatment for depression.

@en

Orthostatic side effects of clomipramine and moclobemide during treatment for depression.

@nl

prefLabel

Orthostatic side effects of clomipramine and moclobemide during treatment for depression.

@en

Orthostatic side effects of clomipramine and moclobemide during treatment for depression.

@nl

P1476

Orthostatic side effects of clomipramine and moclobemide during treatment for depression.

@en

P2093

Danish University Antidepressant Group

http://www.w3.org/2001/XMLSchema#string

Kurt Bjerregaard Bjerregaard Stage

http://www.w3.org/2001/XMLSchema#string

P2860

Moclobemide treatment causes a substantial rise in the sparteine metabolic ratio. Danish University Antidepressant Group.

Development of a rating scale for primary depressive illness

Undesirable blood pressure changes under naturalistic treatment with moclobemide, a reversible MAO-A inhibitor--results of the drug utilization observation studies.

Orthostatic side effects of clomipramine and citalopram during treatment for depression.

Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial.

Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients.

Steady-state plasma levels of clomipramine and its metabolites: impact of the sparteine/debrisoquine oxidation polymorphism. Danish University Antidepressant Group.

Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people.

Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study

P304

298-301

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/08039480500213725

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16195134

http://www.w3.org/2001/XMLSchema#string

Orthostatic side effects of clomipramine and moclobemide during treatment for depression.

about

P2860

P2860

Orthostatic side effects of clomipramine and moclobemide during treatment for depression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698